학술논문

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; MAR 2024, 12 3, pe008409 11p.
Subject
Language
English
ISSN
20511426